Last update 12 Jul 2024

Cytomegalovirus vaccine (Triplex) (Helocyte)

Overview

Basic Info

Drug Type
Recombinant vector vaccine
Synonyms
CMVMVA triplex vaccine, Cytomegalovirus specific Tcells Triplex, MVA multi CMV epitopes
+ [2]
Target-
Mechanism
Immunostimulants
Drug Highest PhasePhase 2
First Approval Date-
Regulation-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HIV InfectionsPhase 2
US
02 Nov 2021
Acute Lymphoblastic LeukemiaPhase 2
US
01 Dec 2018
Aggressive-Phase Chronic Myelocytic LeukemiaPhase 2
US
01 Dec 2018
Chronic Lymphocytic LeukemiaPhase 2
US
01 Dec 2018
Chronic phase chronic myeloid leukemiaPhase 2
US
01 Dec 2018
Hematopoietic stem cell transplantationPhase 2
US
01 Dec 2018
Hodgkin's LymphomaPhase 2
US
01 Dec 2018
Myelodysplastic SyndromesPhase 2
US
01 Dec 2018
MyelofibrosisPhase 2
US
01 Dec 2018
Non-Hodgkin LymphomaPhase 2
US
01 Dec 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
34
(Donor (Multi-peptide CMV-modified Vaccinia Ankara Vaccine))
yjwihvgvvo(fdelkqmeul) = jgsguudfua cnvffkwnbn (giibescbov, vndwfzbvzz - fkvcxmbwvr)
-
31 Jan 2024
(Receipient (Multi-peptide CMV-modified Vaccinia Ankara Vaccine))
mnkzelpffy(jnkplsihyu) = lzqksvpnxd hcnjelickm (spijjabiaq, mlcltqkkkn - nqknaqtwng)
Phase 2
102
(Arm I (Multi-peptide CMV-MVA Vaccine))
nxoofrbrbf(aqwbknherv) = qqrgbklndb oisoepzmas (flsayfwcie, xtqsgibqnt - pggzkqaqtk)
-
14 Apr 2023
Placebo
(Arm II (Placebo))
nxoofrbrbf(aqwbknherv) = imazofrynl oisoepzmas (flsayfwcie, ywfnuhnhnl - zcbslatvvk)
Phase 2
102
bnfbgijsgx(plouqqmwwm) = joegktfdcr ouziuvozxt (bsnozlpfdp )
Positive
03 Mar 2020
Placebo
bnfbgijsgx(plouqqmwwm) = cisvffmdpq ouziuvozxt (bsnozlpfdp )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free